FibroGen, Inc.
METHODS FOR TREATING ANEMIA IN SUBJECTS HAVING KIDNEY FAILURE USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) HYDROXYLASE

Last updated:

Abstract:

The present invention provides methods for treating anemia in a subject having kidney failure by administering a compound that inhibits hypoxia-inducible factor (HIF) prolyl hydroxylase.

Status:
Application
Type:

Utility

Filling date:

5 Aug 2021

Issue date:

2 Dec 2021